NiamhMarieKeeganMD

PubMed

• Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.
  Gleeson, J. P., Keane, F., Keegan, N. M., Mammadov, E., Harrold, E., Alhusaini, A., Harte, J., Eakin-Love, A., O'Halloran, P. J., MacNally, S., Hennessy, B. T., Breath...> ;Cancer medicine. 2019 Nov 23
• 6 citations
  Adding Pertuzumab to Trastuzumab and Taxanes in HER2 positive breast cancer.
  Jack Patrick Gleeson, Niamh M. Keegan, Patrick G. Morris> ;Expert Opinion on Biological Therapy. 2018 Mar 1
• 29 citations
  PI3K inhibition to overcome endocrine resistance in breast cancer.
  Niamh M. Keegan, Jack Patrick Gleeson, Bryan T. Hennessy, Patrick G. Morris> ;Expert Opinion on Investigational Drugs. 2018 Jan 6
• 16 citations
  Comparing attitudes of younger and older patients towards cancer clinical trials
  Olubukola Ayodele, Mateen Akhtar, Aiste Konenko, Niamh Keegan, Flordeliza Calacsan, Lesley Duggan, Miriam O'Connor, Paula Calvert, Carol A. Townsley, Anne M. Horgan> ;Journal of Geriatric Oncology. 2016 May 1
• Join now to see all